We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NA:NASDAQNano Labs Ltd Analysis

Data as of 2026-06-11 - not real-time

$1.99

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Nano Labs Ltd is trading well below its 20‑day (2.41) and 50‑day (2.43) simple moving averages, with the current price of $1.99 also under the 200‑day SMA of 3.63, signaling a clear bearish bias. The RSI sits at 40.6, hinting at modest oversold pressure, while the MACD line remains negative and the histogram is declining, confirming a bearish momentum. Volatility is extreme at 144% over the past 30 days and beta exceeds 1.0, indicating the stock moves sharply with the market and can swing wildly. Valuation multiples are strikingly low – a trailing P/E of 1.97 versus an industry average of 35, and a price‑to‑book of 0.41 – which makes the stock appear deeply discounted. However, the balance sheet is fragile: debt totals $235 M against $37 M in cash, yielding a debt‑to‑equity ratio of 31.8, and both operating and free cash flow are heavily negative. The company’s max drawdown of –89% underscores the historical price collapse risk.
Despite an 18% revenue growth rate and a respectable trailing EPS of $1.01, the business suffers from negative gross (‑26%) and operating margins (‑195%), and the cash‑burn continues. The lack of dividend and a zero forward EPS further diminish income‑generation confidence. Geographic concentration in China adds regulatory and geopolitical headwinds, while the semiconductor sector’s cyclical nature amplifies sector‑specific risk. Overall, the stock’s cheap price may tempt contrarians, but the combination of high leverage, weak cash generation, and volatile price action makes it a high‑risk proposition.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Extreme short‑term volatility and high beta
  • Proximity to support level with limited upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Exceptionally low valuation multiples (P/E, P/B)
  • Revenue growth despite operating losses
  • Heavy debt burden and negative cash flow

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if debt is restructured and cash flow improves
  • Continued exposure to Chinese regulatory environment
  • Fundamental upside from cheap price relative to book value

Key Metrics & Analysis

Financial Health

Revenue Growth18.10%
Profit Margin501.60%
P/E Ratio2.0
ROE25.87%
ROA-5.37%
Debt/Equity31.79
P/B Ratio0.4
Op. Cash Flow$-108268896
Free Cash Flow$-176946048
Industry P/E35.2

Technical Analysis

TrendBearish
RSI40.6
Support$1.85
Resistance$2.95
MA 20$2.41
MA 50$2.43
MA 200$3.63
MACDBearish
VolumeStable
Fear & Greed Index84

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.11
Volatility144.35%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.